胺碘酮治疗冠心病室性心律失常效果分析  

Analysis of treating coronary heart arrhythmia by amiodarone

作　　者：朱振清[1] 秦际德[2] 

机构地区：[1]商丘市第一人民医院药学部,河南商丘476100 [2]商丘市第一人民医院心内科

出　　处：《医药论坛杂志》2015年第4期78-79,共2页Journal of Medical Forum

摘　　要：目的探讨采用胺碘酮治疗冠心病室性心律失常的效果,并观察不良反应。方法将商丘市第一人民医院2012年5月—2014年6月收治的90例冠心病合并室性心律失常病人随机均分作治疗组与对照组,各45例。两组均实施常规的治疗,在此基础,对照组增加莫雷西漆片治疗,治疗组增加胺碘酮治疗。结果治疗后,两组均无严重不良反应。治疗组的室性早搏数及短阵室速数均比对照组具有优势,差异比较显著(P<0.05);治疗组的抗心律失常治疗的总有效显著高于对照组(P<0.05)。结论采用胺碘酮治疗冠心病合并室性心律失常具有明显的疗效,安全性好,可在临床广泛应用。Objective To investigate the effects of amiodarone in treatment of coronary heart arrhythmia, and to observed adverse reactions. Methods Totally 90 patients with coronary artery disease and ventricular arrhythmia patients in our hospital in May 2012 -2014 in June admitted for treatment were randomly divided into two groups, each of 45 cases. Implementation of conventional therapy in both groups, on the basis of the control group increased Moresi paint flakes treatment group amiodarone increases. Results After treatment, there were no serious adverse reactions. Room early number in treatment group and the number of paroxysmal supraventricular tachycardia advantages than the control group, the differences were significant （ P 〈 0. 05 ） ; In treatment group the total effective antiarrhythmic therapy was significantly higher than that of the control group（P 〈 0. 05）. Conclusion The use of amiodarone treatment of coronary heart disease with ventricular arrhythmias have significant efficacy, safety, and can be widely used in clinical practice.

关 键 词：冠心病室性心律失常 胺碘酮 莫雷西漆 

分 类 号：R541.7[医药卫生—心血管疾病]